HEADER UNKNOWN FUNCTION 02-JUL-08 3DNU TITLE STRUCTURE OF MDT PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN HIPA; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 GENE: HIPA, B1507, JW1500; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBAD22 KEYWDS PERSISTENCE, MDT, MULTIDRUG RESISTANCE, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR M.A.SCHUMACHER REVDAT 2 20-OCT-21 3DNU 1 REMARK SEQADV LINK REVDAT 1 27-JAN-09 3DNU 0 JRNL AUTH M.A.SCHUMACHER,K.M.PIRO,W.XU,S.HANSEN,K.LEWIS,R.G.BRENNAN JRNL TITL MOLECULAR MECHANISMS OF HIPA-MEDIATED MULTIDRUG TOLERANCE JRNL TITL 2 AND ITS NEUTRALIZATION BY HIPB. JRNL REF SCIENCE V. 323 396 2009 JRNL REFN ISSN 0036-8075 JRNL PMID 19150849 JRNL DOI 10.1126/SCIENCE.1163806 REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1500604.410 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 58978 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 5982 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.54 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8750 REMARK 3 BIN R VALUE (WORKING SET) : 0.2960 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 968 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3243 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 371 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.23000 REMARK 3 B22 (A**2) : -2.87000 REMARK 3 B33 (A**2) : 7.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.120 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 57.04 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3DNU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1000048268. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9797, 1.02, 0.9796 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59003 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.540 REMARK 200 RESOLUTION RANGE LOW (A) : 43.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : 0.05400 REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.38000 REMARK 200 R SYM FOR SHELL (I) : 0.35000 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, GLYCEROL, PHOSPHATE BUFFER, REMARK 280 PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.90500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 VAL A 110 REMARK 465 THR A 111 REMARK 465 HIS A 112 REMARK 465 PRO A 113 REMARK 465 ASP A 135 REMARK 465 ILE A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 MSE A 140 REMARK 465 ILE A 141 REMARK 465 ARG A 142 REMARK 465 GLU A 143 REMARK 465 GLU A 144 REMARK 465 ASN A 145 REMARK 465 GLY A 185 REMARK 465 GLU A 186 REMARK 465 ILE A 187 REMARK 465 ARG A 188 REMARK 465 GLN A 189 REMARK 465 PRO A 190 REMARK 465 ASN A 191 REMARK 465 ALA A 192 REMARK 465 THR A 193 REMARK 465 LEU A 194 REMARK 465 ASP A 195 REMARK 465 GLY A 438 REMARK 465 SER A 439 REMARK 465 LYS A 440 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 268 O HOH A 1005 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 10 -1.72 72.39 REMARK 500 ARG A 148 77.09 -113.98 REMARK 500 GLN A 155 -144.85 -105.55 REMARK 500 THR A 158 -159.21 -133.07 REMARK 500 THR A 343 -82.04 -72.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 441 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 833 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 834 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 835 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3DNT RELATED DB: PDB REMARK 900 SAME PROTEIN IN ATP BOUND FORM REMARK 900 RELATED ID: 3DNV RELATED DB: PDB REMARK 900 RELATED ID: 3DNW RELATED DB: PDB DBREF 3DNU A 1 440 UNP P23874 HIPA_ECOLI 1 440 SEQADV 3DNU GLN A 309 UNP P23874 ASP 309 ENGINEERED MUTATION SEQRES 1 A 440 MSE PRO LYS LEU VAL THR TRP MSE ASN ASN GLN ARG VAL SEQRES 2 A 440 GLY GLU LEU THR LYS LEU ALA ASN GLY ALA HIS THR PHE SEQRES 3 A 440 LYS TYR ALA PRO GLU TRP LEU ALA SER ARG TYR ALA ARG SEQRES 4 A 440 PRO LEU SER LEU SER LEU PRO LEU GLN ARG GLY ASN ILE SEQRES 5 A 440 THR SER ASP ALA VAL PHE ASN PHE PHE ASP ASN LEU LEU SEQRES 6 A 440 PRO ASP SER PRO ILE VAL ARG ASP ARG ILE VAL LYS ARG SEQRES 7 A 440 TYR HIS ALA LYS SER ARG GLN PRO PHE ASP LEU LEU SER SEQRES 8 A 440 GLU ILE GLY ARG ASP SER VAL GLY ALA VAL THR LEU ILE SEQRES 9 A 440 PRO GLU ASP GLU THR VAL THR HIS PRO ILE MSE ALA TRP SEQRES 10 A 440 GLU LYS LEU THR GLU ALA ARG LEU GLU GLU VAL LEU THR SEQRES 11 A 440 ALA TYR LYS ALA ASP ILE PRO LEU GLY MSE ILE ARG GLU SEQRES 12 A 440 GLU ASN ASP PHE ARG ILE SER VAL ALA GLY ALA GLN GLU SEQRES 13 A 440 LYS THR ALA LEU LEU ARG ILE GLY ASN ASP TRP CYS ILE SEQRES 14 A 440 PRO LYS GLY ILE THR PRO THR THR HIS ILE ILE LYS LEU SEQRES 15 A 440 PRO ILE GLY GLU ILE ARG GLN PRO ASN ALA THR LEU ASP SEQRES 16 A 440 LEU SER GLN SER VAL ASP ASN GLU TYR TYR CYS LEU LEU SEQRES 17 A 440 LEU ALA LYS GLU LEU GLY LEU ASN VAL PRO ASP ALA GLU SEQRES 18 A 440 ILE ILE LYS ALA GLY ASN VAL ARG ALA LEU ALA VAL GLU SEQRES 19 A 440 ARG PHE ASP ARG ARG TRP ASN ALA GLU ARG THR VAL LEU SEQRES 20 A 440 LEU ARG LEU PRO GLN GLU ASP MSE CYS GLN THR PHE GLY SEQRES 21 A 440 LEU PRO SER SER VAL LYS TYR GLU SER ASP GLY GLY PRO SEQRES 22 A 440 GLY ILE ALA ARG ILE MSE ALA PHE LEU MSE GLY SER SER SEQRES 23 A 440 GLU ALA LEU LYS ASP ARG TYR ASP PHE MSE LYS PHE GLN SEQRES 24 A 440 VAL PHE GLN TRP LEU ILE GLY ALA THR GLN GLY HIS ALA SEQRES 25 A 440 LYS ASN PHE SER VAL PHE ILE GLN ALA GLY GLY SER TYR SEQRES 26 A 440 ARG LEU THR PRO PHE TYR ASP ILE ILE SER ALA PHE PRO SEQRES 27 A 440 VAL LEU GLY GLY THR GLY ILE HIS ILE SER ASP LEU LYS SEQRES 28 A 440 LEU ALA MSE GLY LEU ASN ALA SER LYS GLY LYS LYS THR SEQRES 29 A 440 ALA ILE ASP LYS ILE TYR PRO ARG HIS PHE LEU ALA THR SEQRES 30 A 440 ALA LYS VAL LEU ARG PHE PRO GLU VAL GLN MSE HIS GLU SEQRES 31 A 440 ILE LEU SER ASP PHE ALA ARG MSE ILE PRO ALA ALA LEU SEQRES 32 A 440 ASP ASN VAL LYS THR SER LEU PRO THR ASP PHE PRO GLU SEQRES 33 A 440 ASN VAL VAL THR ALA VAL GLU SER ASN VAL LEU ARG LEU SEQRES 34 A 440 HIS GLY ARG LEU SER ARG GLU TYR GLY SER LYS MODRES 3DNU MSE A 8 MET SELENOMETHIONINE MODRES 3DNU MSE A 115 MET SELENOMETHIONINE MODRES 3DNU MSE A 255 MET SELENOMETHIONINE MODRES 3DNU MSE A 279 MET SELENOMETHIONINE MODRES 3DNU MSE A 283 MET SELENOMETHIONINE MODRES 3DNU MSE A 296 MET SELENOMETHIONINE MODRES 3DNU MSE A 354 MET SELENOMETHIONINE MODRES 3DNU MSE A 388 MET SELENOMETHIONINE MODRES 3DNU MSE A 398 MET SELENOMETHIONINE HET MSE A 8 8 HET MSE A 115 8 HET MSE A 255 8 HET MSE A 279 8 HET MSE A 283 8 HET MSE A 296 8 HET MSE A 354 8 HET MSE A 388 8 HET MSE A 398 8 HET CL A 441 1 HET PO4 A 833 5 HET PO4 A 834 5 HET PO4 A 835 5 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM PO4 PHOSPHATE ION FORMUL 1 MSE 9(C5 H11 N O2 SE) FORMUL 2 CL CL 1- FORMUL 3 PO4 3(O4 P 3-) FORMUL 6 HOH *371(H2 O) HELIX 1 1 ALA A 29 SER A 35 1 7 HELIX 2 2 SER A 54 ASN A 63 1 10 HELIX 3 3 SER A 68 HIS A 80 1 13 HELIX 4 4 GLN A 85 GLY A 94 1 10 HELIX 5 5 THR A 121 ALA A 131 1 11 HELIX 6 6 GLN A 198 LEU A 213 1 16 HELIX 7 7 MSE A 255 PHE A 259 1 5 HELIX 8 8 PRO A 262 LYS A 266 5 5 HELIX 9 9 TYR A 267 GLY A 271 5 5 HELIX 10 10 GLY A 274 MSE A 283 1 10 HELIX 11 11 GLU A 287 ILE A 305 1 19 HELIX 12 12 HIS A 311 ASN A 314 5 4 HELIX 13 13 ALA A 321 GLY A 323 5 3 HELIX 14 14 ALA A 336 LEU A 340 5 5 HELIX 15 15 HIS A 346 ASP A 349 5 4 HELIX 16 16 ASP A 367 ILE A 369 5 3 HELIX 17 17 TYR A 370 LEU A 381 1 12 HELIX 18 18 PRO A 384 LYS A 407 1 24 HELIX 19 19 THR A 408 LEU A 410 5 3 HELIX 20 20 PRO A 415 ARG A 435 1 21 SHEET 1 A 4 HIS A 24 TYR A 28 0 SHEET 2 A 4 GLN A 11 LYS A 18 -1 N THR A 17 O THR A 25 SHEET 3 A 4 LYS A 3 MSE A 8 -1 N THR A 6 O VAL A 13 SHEET 4 A 4 VAL A 101 PRO A 105 -1 O THR A 102 N TRP A 7 SHEET 1 B 6 TRP A 117 LYS A 119 0 SHEET 2 B 6 ASP A 166 PRO A 170 -1 O ILE A 169 N GLU A 118 SHEET 3 B 6 THR A 158 ILE A 163 -1 N LEU A 161 O CYS A 168 SHEET 4 B 6 HIS A 178 LYS A 181 -1 O ILE A 180 N THR A 158 SHEET 5 B 6 VAL A 228 GLU A 234 -1 O VAL A 233 N ILE A 179 SHEET 6 B 6 ALA A 220 ALA A 225 -1 N GLU A 221 O ALA A 232 SHEET 1 C 2 ARG A 238 TRP A 240 0 SHEET 2 C 2 LEU A 247 ARG A 249 -1 O LEU A 248 N ARG A 239 SHEET 1 D 3 GLN A 252 ASP A 254 0 SHEET 2 D 3 SER A 316 ILE A 319 -1 O VAL A 317 N GLU A 253 SHEET 3 D 3 TYR A 325 LEU A 327 -1 O ARG A 326 N PHE A 318 SHEET 1 E 2 LYS A 351 ALA A 358 0 SHEET 2 E 2 GLY A 361 ALA A 365 -1 O LYS A 363 N LEU A 356 LINK C TRP A 7 N MSE A 8 1555 1555 1.33 LINK C MSE A 8 N ASN A 9 1555 1555 1.32 LINK C ILE A 114 N MSE A 115 1555 1555 1.33 LINK C MSE A 115 N ALA A 116 1555 1555 1.33 LINK C ASP A 254 N MSE A 255 1555 1555 1.33 LINK C MSE A 255 N CYS A 256 1555 1555 1.33 LINK C ILE A 278 N MSE A 279 1555 1555 1.34 LINK C MSE A 279 N ALA A 280 1555 1555 1.34 LINK C LEU A 282 N MSE A 283 1555 1555 1.33 LINK C MSE A 283 N GLY A 284 1555 1555 1.34 LINK C PHE A 295 N MSE A 296 1555 1555 1.34 LINK C MSE A 296 N LYS A 297 1555 1555 1.34 LINK C ALA A 353 N MSE A 354 1555 1555 1.34 LINK C MSE A 354 N GLY A 355 1555 1555 1.33 LINK C GLN A 387 N MSE A 388 1555 1555 1.33 LINK C MSE A 388 N HIS A 389 1555 1555 1.34 LINK C ARG A 397 N MSE A 398 1555 1555 1.34 LINK C MSE A 398 N ILE A 399 1555 1555 1.34 SITE 1 AC1 6 GLY A 164 ASN A 165 LYS A 363 THR A 364 SITE 2 AC1 6 ALA A 365 HOH A 985 SITE 1 AC2 7 ALA A 358 SER A 359 LYS A 363 ARG A 372 SITE 2 AC2 7 HIS A 373 HOH A 964 HOH A1046 SITE 1 AC3 4 ARG A 39 GLN A 320 ALA A 321 HOH A1191 SITE 1 AC4 3 GLN A 48 ARG A 49 HOH A1176 CRYST1 48.660 85.810 49.670 90.00 90.00 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020551 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011654 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020133 0.00000